PubRank

C Verhoef

Author PubWeight™ 64.67‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Randomized clinical trial comparing feeding jejunostomy with nasoduodenal tube placement in patients undergoing oesophagectomy. Br J Surg 2007 3.05
2 Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg 2012 2.65
3 Genetics and biochemistry of the peptidoglycan-associated proteins b and c of Escherichia coli K12. Mol Gen Genet 1979 2.48
4 Recombination in Escherichia coli. 3. Mapping by the gradient of transmission. Mutat Res 1970 2.45
5 Mapping of a gene for a major outer membrane protein of Escherichia coli K12 with the aid of a newly isolated bacteriophage. Mol Gen Genet 1977 2.31
6 Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative? Ann Oncol 2006 2.30
7 The dual genetic control of ornithine transcarbamylase synthesis in Escherichia coli K12. Mutat Res 1968 1.97
8 Genetic recombination in Escherichia coli. I. Relation between linkage of unselected markers and map distance. Mutat Res 1966 1.87
9 meoA is the structural gene for outer membrane protein c of Escherichia coli K12. Mol Gen Genet 1979 1.70
10 Optimizing the outcome of surgery in patients with rectal cancer and synchronous liver metastases. Br J Surg 2010 1.65
11 Aggressive angiomyxoma: multimodality treatments can avoid mutilating surgery. Eur J Surg Oncol 2006 1.61
12 Genetic recombination in Escherichia coli. IV. Isolation and characterization of recombination-deficiency mutants of Escherichia coli K12. Mutat Res 1971 1.52
13 Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary (Br J Surg 2006; 93; 872-878). Br J Surg 2007 1.40
14 Stereotactic body radiation therapy for colorectal liver metastases. Br J Surg 2010 1.35
15 Pore protein e of the outer membrane of Escherichia coli K12. FEBS Lett 1978 1.33
16 Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population-based series. Colorectal Dis 2012 1.30
17 Genetic recombination in Escherichia coli. II. Calculation of incorporation frequency and relative map distance by recombinant analysis. Mutat Res 1966 1.30
18 Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma. Eur J Surg Oncol 2006 1.15
19 Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer. Eur J Surg Oncol 2006 1.13
20 A new approach for rapid and reliable enumeration of circulating endothelial cells in patients. J Thromb Haemost 2012 1.08
21 Influence of margins on overall survival after hepatic resection for colorectal metastasis: a meta-analysis. Ann Surg 2015 1.06
22 Radiofrequency ablation in patients with primary and secondary hepatic malignancies. J Gastrointest Surg 2006 1.03
23 Total pelvic exenteration for primary and recurrent malignancies. World J Surg 2009 1.02
24 Cervical lymph node dissection for metastatic testicular cancer. Ann Surg Oncol 2010 0.95
25 'Staged' liver resection in synchronous and metachronous colorectal hepatic metastases: differences in clinicopathological features and outcome. Colorectal Dis 2010 0.95
26 High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma. Eur J Cancer 2006 0.94
27 TNF dose reduction in isolated limb perfusion. Eur J Surg Oncol 2005 0.91
28 Forequarter amputation for malignancy. Br J Surg 2009 0.91
29 Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib. Eur J Surg Oncol 2012 0.91
30 Cloning and expression in Escherichia coli K-12 of the structural gene for outer membrane PhoE protein from Enterobacter cloacae. Gene 1984 0.89
31 Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery (CARTS study). Br J Surg 2015 0.89
32 Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases. Br J Surg 2011 0.88
33 Therapeutic surgical management of palpable melanoma groin metastases: superficial or combined superficial and deep groin lymph node dissection. Ann Surg Oncol 2011 0.86
34 Local recurrence after surgery for primary extra-abdominal desmoid-type fibromatosis. Br J Surg 2013 0.85
35 Resection of liver metastases in patients with breast cancer: survival and prognostic factors. Eur J Surg Oncol 2012 0.85
36 Imaging modalities for the staging of patients with colorectal cancer. Neth J Med 2012 0.83
37 Preoperative chemoradiation with capecitabine in locally advanced rectal cancer. Neth J Med 2008 0.83
38 New pore protein produced in cells lysogenic for Escherichia coli phage HK253hrk. Eur J Biochem 1987 0.81
39 Abdominosacral resection for locally advanced and recurrent rectal cancer. Br J Surg 2009 0.81
40 Quantitative HBV DNA and AST are strong predictors for survival after HCC detection in chronic HBV patients. Neth J Med 2012 0.80
41 Primary and secondary reconstruction after surgery of the irradiated pelvis using a gracilis muscle flap transposition. Eur J Surg Oncol 2005 0.80
42 Hepatic steatosis assessment with CT or MRI in patients with colorectal liver metastases after neoadjuvant chemotherapy. J Surg Oncol 2011 0.79
43 TNF-based isolated limb perfusion in unresectable extremity desmoid tumours. Eur J Surg Oncol 2005 0.79
44 Isolated limb perfusion using tumour necrosis factor α and melphalan in patients with advanced aggressive fibromatosis. Br J Surg 2014 0.78
45 Isolated tumor cells and long-term prognosis of patients with melanoma. Ann Surg Oncol 2008 0.78
46 Sentinel node biopsy for clear cell sarcoma. Eur J Surg Oncol 2006 0.78
47 Local excision of rectal cancer after chemoradiation: feasibility depends on the primary stage. Int J Colorectal Dis 2010 0.78
48 Hepatocellular carcinoma: Dutch guideline for surveillance, diagnosis and therapy. Neth J Med 2014 0.77
49 Prognosis in patients with sentinel node-positive melanoma without immediate completion lymph node dissection. Br J Surg 2012 0.77
50 Recombination in Escherichia coli. V. Genetic analysis of recombinants from crosses with recipients deficient in ATP-dependent exonuclease activity. Mutat Res 1972 0.76
51 Cutaneous melanoma and sentinel lymph node biopsy. Ann Surg Oncol 2008 0.76
52 A place for radiofrequency ablation in the treatment of resectable colorectal liver metastases? Ann Surg Oncol 2008 0.76
53 Isolated hypoxic hepatic perfusion with melphalan in patients with irresectable ocular melanoma metastases. Eur J Surg Oncol 2008 0.76
54 Systemic treatment in hepatocellular carcinoma; 'A small step for man...'. Neth J Med 2009 0.75
55 Response to chemotherapy in patients with recurrent rectal cancer in previously irradiated area. Int J Colorectal Dis 2015 0.75
56 [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients]. Ned Tijdschr Geneeskd 2005 0.75
57 Utility of repeat radiofrequency ablation to provide long-term local control in recurrent rectal cancer. Surgery 2006 0.75
58 The Prognostic Value of Post-operative Serum C-reactive Protein Level for -Survival after Surgery for Colorectal Liver Metastases. Acta Chir Belg 2015 0.75
59 Isolated hypoxic liver perfusion with melfalan in humans and its anesthesiologic aspects. Adv Exp Med Biol 2012 0.75
60 [Local approval procedures act as a brake on RCTs]. Ned Tijdschr Geneeskd 2016 0.75
61 Preoperative FDG-PET-scan in patients with resectable colorectal liver metastases does not improve overall survival: a retrospective analyses stratified by clinical risk score. Dig Surg 2014 0.75
62 Hepatocellular carcinoma after danazol treatment for hereditary angio-oedema. Neth J Med 2014 0.75
63 Safety and efficacy of a novel, dry powder fibrin sealant for hemostasis in hepatic resection. Dig Surg 2015 0.75